Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

776 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML.
Schlegel P, Ditthard K, Lang P, Mezger M, Michaelis S, Handgretinger R, Pfeiffer M. Schlegel P, et al. J Immunol Res. 2015;2015:473175. doi: 10.1155/2015/473175. Epub 2015 Jul 8. J Immunol Res. 2015. PMID: 26236752 Free PMC article.
Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors.
Lang P, Pfeiffer M, Teltschik HM, Schlegel P, Feuchtinger T, Ebinger M, Klingebiel T, Bader P, Schlegel PG, Beck J, Greil J, Handgretinger R. Lang P, et al. Among authors: schlegel pg, schlegel p. Best Pract Res Clin Haematol. 2011 Sep;24(3):403-11. doi: 10.1016/j.beha.2011.04.009. Epub 2011 Jun 25. Best Pract Res Clin Haematol. 2011. PMID: 21925093
Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children.
Schlegel P, Teltschik HM, Pfeiffer M, Handgretinger R, Schumm M, Koscielniak E, Feuchtinger T, Klingebiel T, Bader P, Schlegel PG, Greil J, Lang P. Schlegel P, et al. Among authors: schlegel pg. Best Pract Res Clin Haematol. 2011 Sep;24(3):443-52. doi: 10.1016/j.beha.2011.04.007. Epub 2011 Jun 25. Best Pract Res Clin Haematol. 2011. PMID: 21925097
Emerging role of immunotherapy for childhood cancers.
Handgretinger R, Schlegel P. Handgretinger R, et al. Among authors: schlegel p. Chin Clin Oncol. 2018 Apr;7(2):14. doi: 10.21037/cco.2018.04.06. Chin Clin Oncol. 2018. PMID: 29764159 Free article. Review.
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity.
Schlegel P, Lang AM, Matela M, Horrer A, Schilling A, Jöchner A, Wiedenmann M, Seitz C, Döring M, Feuchtinger T, Heubach F, Rabsteyn A, Handgretinger R, Lang P. Schlegel P, et al. Bone Marrow Transplant. 2019 Aug;54(Suppl 2):727-732. doi: 10.1038/s41409-019-0609-y. Bone Marrow Transplant. 2019. PMID: 31431711
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
Seitz CM, Flaadt T, Mezger M, Lang AM, Michaelis S, Katz M, Syring D, Joechner A, Rabsteyn A, Siebert N, Troschke-Meurer S, Zumpe M, Lode HN, Yang SF, Atar D, Mast AS, Scheuermann S, Heubach F, Handgretinger R, Lang P, Schlegel P. Seitz CM, et al. Among authors: schlegel p. Front Immunol. 2021 Jul 22;12:690467. doi: 10.3389/fimmu.2021.690467. eCollection 2021. Front Immunol. 2021. PMID: 34367149 Free PMC article. Clinical Trial.
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.
Schlegel P, Lang P, Zugmaier G, Ebinger M, Kreyenberg H, Witte KE, Feucht J, Pfeiffer M, Teltschik HM, Kyzirakos C, Feuchtinger T, Handgretinger R. Schlegel P, et al. Haematologica. 2014 Jul;99(7):1212-9. doi: 10.3324/haematol.2013.100073. Epub 2014 Apr 11. Haematologica. 2014. PMID: 24727818 Free PMC article.
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody.
Seidel UJ, Schlegel P, Grosse-Hovest L, Hofmann M, Aulwurm S, Pyz E, Schuster FR, Meisel R, Ebinger M, Feuchtinger T, Teltschik HM, Witte KE, Schwarze CP, Rammensee HG, Handgretinger R, Jung G, Lang P. Seidel UJ, et al. Among authors: schlegel p. Mol Ther. 2016 Sep;24(9):1634-43. doi: 10.1038/mt.2016.141. Epub 2016 Jul 6. Mol Ther. 2016. PMID: 27380762 Free PMC article.
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts.
Feucht J, Kayser S, Gorodezki D, Hamieh M, Döring M, Blaeschke F, Schlegel P, Bösmüller H, Quintanilla-Fend L, Ebinger M, Lang P, Handgretinger R, Feuchtinger T. Feucht J, et al. Among authors: schlegel p. Oncotarget. 2016 Nov 22;7(47):76902-76919. doi: 10.18632/oncotarget.12357. Oncotarget. 2016. PMID: 27708227 Free PMC article.
776 results